Cargando…

Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital, Northwest Ethiopia: a case–control study

BACKGROUND: Viral load monitoring is used as an important biomarker for diagnosing treatment failure in patients with HIV infection/AIDS. Ethiopia has started targeted viral load monitoring. However, factors leading to virological failure are not well understood and studied. Thus, the aim of this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayu, Belete, Tariku, Amare, Bulti, Abera Balcha, Habitu, Yohannes Ayanaw, Derso, Terefe, Teshome, Destaw Fetene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557910/
https://www.ncbi.nlm.nih.gov/pubmed/28848364
http://dx.doi.org/10.2147/HIV.S139516
_version_ 1783257296473686016
author Bayu, Belete
Tariku, Amare
Bulti, Abera Balcha
Habitu, Yohannes Ayanaw
Derso, Terefe
Teshome, Destaw Fetene
author_facet Bayu, Belete
Tariku, Amare
Bulti, Abera Balcha
Habitu, Yohannes Ayanaw
Derso, Terefe
Teshome, Destaw Fetene
author_sort Bayu, Belete
collection PubMed
description BACKGROUND: Viral load monitoring is used as an important biomarker for diagnosing treatment failure in patients with HIV infection/AIDS. Ethiopia has started targeted viral load monitoring. However, factors leading to virological failure are not well understood and studied. Thus, the aim of this study was to identify the determinants of virological failure among HIV-infected patients on highly active antiretroviral therapy at the University of Gondar Referral Hospital, Northwest Ethiopia. METHODS: A case–control study was conducted from May to June 2015. Cases were subjects who had already experienced virological failure; controls were those without virological failure. Data were extracted from 153 cases and 153 controls through chart review. A multivariate logistic regression analysis was carried out to identify factors associated with virological failure, and variables with a p-value <0.05 were considered statistically significant. RESULTS: In this study, higher odds of virological failure was observed among patients aged <35 years (adjusted odds ratio [AOR] =2.52, 95% CI: 1.33, 4.77), who had had CD4+ count <200 cells/mm(3) (AOR=9.03, 95% CI: 4.40, 18.50), showed poor adherence to antiretroviral therapy (ART) (AOR=15.80, 95% CI: 6.90, 36.50), and had taken ART for longer durations of 25–47 months (AOR=3.00, 95% CI: 1.10, 8.40) and ≥48 months (AOR=6.70, 95% CI: 2.70, 16.60). CONCLUSION: This study showed that patients aged <35 years and with recent low CD4 count, poor adherence to treatment, and longer exposure to ART were positively and significantly associated with virological treatment failure. Therefore, evidence-based intervention should be implemented to improve adherence to ART, which in turn helps to boost immunity (CD4) and suppresses viral replication and load. Moreover, attention should be given to younger patients who have had ART for longer periods.
format Online
Article
Text
id pubmed-5557910
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-55579102017-08-28 Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital, Northwest Ethiopia: a case–control study Bayu, Belete Tariku, Amare Bulti, Abera Balcha Habitu, Yohannes Ayanaw Derso, Terefe Teshome, Destaw Fetene HIV AIDS (Auckl) Original Research BACKGROUND: Viral load monitoring is used as an important biomarker for diagnosing treatment failure in patients with HIV infection/AIDS. Ethiopia has started targeted viral load monitoring. However, factors leading to virological failure are not well understood and studied. Thus, the aim of this study was to identify the determinants of virological failure among HIV-infected patients on highly active antiretroviral therapy at the University of Gondar Referral Hospital, Northwest Ethiopia. METHODS: A case–control study was conducted from May to June 2015. Cases were subjects who had already experienced virological failure; controls were those without virological failure. Data were extracted from 153 cases and 153 controls through chart review. A multivariate logistic regression analysis was carried out to identify factors associated with virological failure, and variables with a p-value <0.05 were considered statistically significant. RESULTS: In this study, higher odds of virological failure was observed among patients aged <35 years (adjusted odds ratio [AOR] =2.52, 95% CI: 1.33, 4.77), who had had CD4+ count <200 cells/mm(3) (AOR=9.03, 95% CI: 4.40, 18.50), showed poor adherence to antiretroviral therapy (ART) (AOR=15.80, 95% CI: 6.90, 36.50), and had taken ART for longer durations of 25–47 months (AOR=3.00, 95% CI: 1.10, 8.40) and ≥48 months (AOR=6.70, 95% CI: 2.70, 16.60). CONCLUSION: This study showed that patients aged <35 years and with recent low CD4 count, poor adherence to treatment, and longer exposure to ART were positively and significantly associated with virological treatment failure. Therefore, evidence-based intervention should be implemented to improve adherence to ART, which in turn helps to boost immunity (CD4) and suppresses viral replication and load. Moreover, attention should be given to younger patients who have had ART for longer periods. Dove Medical Press 2017-08-08 /pmc/articles/PMC5557910/ /pubmed/28848364 http://dx.doi.org/10.2147/HIV.S139516 Text en © 2017 Bayu et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Bayu, Belete
Tariku, Amare
Bulti, Abera Balcha
Habitu, Yohannes Ayanaw
Derso, Terefe
Teshome, Destaw Fetene
Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital, Northwest Ethiopia: a case–control study
title Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital, Northwest Ethiopia: a case–control study
title_full Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital, Northwest Ethiopia: a case–control study
title_fullStr Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital, Northwest Ethiopia: a case–control study
title_full_unstemmed Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital, Northwest Ethiopia: a case–control study
title_short Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital, Northwest Ethiopia: a case–control study
title_sort determinants of virological failure among patients on highly active antiretroviral therapy in university of gondar referral hospital, northwest ethiopia: a case–control study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557910/
https://www.ncbi.nlm.nih.gov/pubmed/28848364
http://dx.doi.org/10.2147/HIV.S139516
work_keys_str_mv AT bayubelete determinantsofvirologicalfailureamongpatientsonhighlyactiveantiretroviraltherapyinuniversityofgondarreferralhospitalnorthwestethiopiaacasecontrolstudy
AT tarikuamare determinantsofvirologicalfailureamongpatientsonhighlyactiveantiretroviraltherapyinuniversityofgondarreferralhospitalnorthwestethiopiaacasecontrolstudy
AT bultiaberabalcha determinantsofvirologicalfailureamongpatientsonhighlyactiveantiretroviraltherapyinuniversityofgondarreferralhospitalnorthwestethiopiaacasecontrolstudy
AT habituyohannesayanaw determinantsofvirologicalfailureamongpatientsonhighlyactiveantiretroviraltherapyinuniversityofgondarreferralhospitalnorthwestethiopiaacasecontrolstudy
AT dersoterefe determinantsofvirologicalfailureamongpatientsonhighlyactiveantiretroviraltherapyinuniversityofgondarreferralhospitalnorthwestethiopiaacasecontrolstudy
AT teshomedestawfetene determinantsofvirologicalfailureamongpatientsonhighlyactiveantiretroviraltherapyinuniversityofgondarreferralhospitalnorthwestethiopiaacasecontrolstudy